- Curriculum vitae ITA: Scarica allegato
- Citation Index: 564
- Publication (PubMed): https://pubmed.ncbi.nlm.nih.gov/?term=%28Zanoni+Michele%29+AND+%28IRST%29&sort=pubdate
- H-Index & Publication (Scopus): https://www.scopus.com/authid/detail.uri?authorId=55499297500
- ORCID (Id): https://orcid.org/0000-0003-1826-9430
Dr’s Zanoni work is focused on preclinical and translational research regarding the cellular and molecular biology of tumor cell and tumor microenvironment. He has been involved in several projects on cancer pharmacology, radiobiology, circulating or tissue biomarkers with prognostic relevance for bone metastasis, studies on cancer-stromal cell interactions, cancer stem cells’ isolation and characterization, and zebrafish model to study brain cancer biology. His research is focused on three-dimensional (3D) models and tumor microenvironment with the goal of understand how the tumor microenvironment, in terms of cellular, physical and biochemical composition, could affect tumor progression and metastatic spread as well as response to therapy. In particular he is focused on glioblastoma multiforme (GBM) and brain metastases derived from different primary tumors. He also gained his PhD in Molecular Medicine and Pharmacology at University of Ferrara studying the role of P2X7 receptor and nucleotides (ATP) in GBM progression, inflammation, invasiveness and in correlation with chemo-radio therapy resistance.